This notice has been initiated due to potential for compromised test card Top Seal Integrity which could:
- yield false resistance for antibiotics on the AST panel
- cause a false negative ESBL Test
- result in a false positive urea (URE) reaction on ID cards
Source facts
Action
The recall was issued to bioMrieux subsidiaries and distributors via email notification on Friday, January 11th, 2019.
Impacted customers were notified via correction notice (customer letter) issued on 01/19/2019 from each associated subsidiary/distributor onto local letterhead. The letter directed the user to perform a "tug test" to determine if the product is defective. Defective units were to be discarded and a credit issued.
Initiated
2019-01-11
Root cause
Process control
Terminated
2020-11-06
Distribution
Worldwide distribution.
Recall number
Z-0962-2019
Recall status
Terminated
CDRH record ID
170347
FDA record created
2019-02-27
Recall event number
81934
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.